2 ms·
They will probably have a hard time with marketing to consumers , because of the alternatives, and the fact that this is limited to a single diagnostic type:
by petra 9y ago
They will probably have a hard time with marketing to consumers , because of the alternatives, and the fact that this is limited to a single diagnostic type:
1. Walmart is working with Quest on offering blood testing services on site.
2. This Australian site:https://www.myhealthtest.com https://www.myhealthtest.com is offering mail-order testing services, for some things(for many you need a phlebotomist to draw blood, but maybe that will change[a])
[a]Startups are working on lab-on-test diagnostics, which require small volume, but there's still scientific debate whether sampling blood via finger-prick is pure enough for testing.
- QAPereo 9y agoIt's crazy to me that these products are going to be marketed while there is still debate to be had. This is medicine not software development, and efficacy should be the first thing on the table, then safety and reproducibility. Without that what exactly is being invested in here?
- petra 9y agoI don't think that without serious research proving to doctors that this works in this case, they'll have a chance. The diagnosis they are going after is cancer, so people do what their doctors tell them.
- jforman 9y agoRequestatest.com also offers Quest (& LabCorp in some states) DTC orders, and Everlywell does the sample-collection-by-mail thing in the US as well.